 |
|
2013
The CIN4 chromosomal instability qPCR classifier defines tumor aneuploidy and stratifies outcome in grade 2 breast cancer.
Szász AM, Li Q, Eklund AC, Sztupinszki Z, Rowan A, Tõkés AM, Székely B, Kiss A, Szendrõi M, Gyõrffy B, Szállási Z, Swanton C, Kulka J
PLoS One. 2013;, 2013 |
PubMed
Relevant URL
|
Deconvoluting complex tissues for expression quantitative trait locus-based analyses.
Seo JH, Li Q, Fatima A, Eklund A, Szallasi Z, Polyak K, Richardson AL, Freedman ML
Philos Trans R Soc Lond B Biol Sci., 2013 |
PubMed
Relevant URL
|
2012
Telomeric allelic imbalance indicates defective DNA repair and sensitivity to DNA-damaging agents
Birkbak NJ, Wang ZC, Kim JY, Eklund AC, Li Q, Tian R, Bowman-Colin C, Li Y, Greene-Colozzi A, Iglehart JD, Tung N, Ryan PD, Garber JE, Silver DP, Szallasi Z, Richardson AL
Cancer Discov. 2012 Apr;2(4):366-75. Epub 2012 Mar 22., 2012 |
PubMed
|
Prediction of drug efficacy for cancer treatment based on comparative analysis of chemosensitivity and gene expression data
Wan P, Li Q, Larsen JE, Eklund AC, Parlesak A, Rigina O, Nielsen SJ, Björkling F, Jónsdóttir SÓ
Bioorg Med Chem., 2012 |
PubMed
Relevant URL
|
2011
Jetset: selecting the optimal microarray probe set to represent a gene
Li Q, Birkbak NJ, Gyorffy B, Szallasi Z, Eklund AC
BMC Bioinformatics, 2011 |
PubMed
|
Consistent metagenes from cancer expression profiles yield agent specific predictors of chemotherapy response
Li Q, Eklund AC, Birkbak NJ, Desmedt C, Haibe-Kains B, Sotiriou C, Symmans WF, Pusztai L, Brunak S, Richardson AL, Szallasi Z
BMC Bioinformatics, July 28, 2011 |
PubMed
|
Paradoxical relationship between chromosomal instability and survival outcome in cancer
Birkbak NJ, Eklund AC, Li Q, McClelland SE, Endesfelder D, Tan P, Tan IB, Richardson AL, Szallasi Z, Swanton C
Cancer Research, January 26, 2011 |
PubMed
|
2010
Minimising Immunohistochemical False Negative ER Classification Using a Complementary 23 Gene Expression Signature of ER Status
Li Q, Eklund AC, Juul N, Haibe-Kains B, Workman CT, Richardson AL, Szallasi Z, Swanton C
PLoS One, December 1, 2010 |
PubMed
|
Assessment of an RNA interference screen-derived mitotic and ceramide pathway metagene as a predictor of response to neoadjuvant paclitaxel for primary triple-negative breast cancer: a retrospective analysis of five clinical trials
Juul N, Szallasi Z, Eklund AC, Li Q, Burrell RA, Gerlinger M, Valero V, Andreopoulou E, Esteva FJ, Symmans WF, Desmedt C, Haibe-Kains B, Sotiriou C, Pusztai L, Swanton C
Lancet Oncol., 2010 |
PubMed
|
Amplification of LAPTM4B and YWHAZ contributes to chemotherapy resistance and recurrence of breast cancer
Li Y, Zou L, Li Q, Haibe-Kains B, Tian R, Li Y, Desmedt C, Sotiriou C, Szallasi Z, Iglehart JD, Richardson AL, Wang ZC
Nat Med, 2010 |
PubMed
|
Efficacy of Neoadjuvant Cisplatin in Triple-Negative Breast Cancer
Silver DP, Richardson AL, Eklund AC, Wang ZC, Szallasi Z, Li Q, Juul N, Leong CO, Calogrias D, Buraimoh A, Fatima A, Gelman RS, Ryan PD, Tung NM, De Nicolo A, Ganesan S, Miron A, Colin C, Sgroi DC, Ellisen LW, Winer EP, Garber JE
J Clin Oncol, 2010 |
PubMed
|
2009
An online survival analysis tool to rapidly assess the effect of 22,277 genes on breast cancer prognosis using microarray data of 1,809 patients
Györffy B, Lanczky A, Eklund AC, Denkert C, Budczies J, Li Q, Szallasi Z
Breast Cancer Res Treat, 2009 |
PubMed
|
Chromosomal instability determines taxane response
Swanton C, Nicke B, Schuett M, Eklund AC, Ng C, Li Q, Hardcastle T, Lee A, Roy R, East P, Kschischo M, Endesfelder D, Wylie P, Kim SN, Chen JG, Howell M, Ried T, Habermann JK, Auer G, Brenton JD, Szallasi Z, Downward J
Proc Natl Acad Sci U S A;106(21):8671-6, 2009 |
PubMed
|
2008
hERG Classification Model Based on a Combination of Support Vector Machine Method and GRIND Descriptors
Li Q, Jørgensen FS, Oprea T, Brunak S, Taboureau O
Mol Pharm,4;5(1):117-127, 2008 |
PubMed
|
|
|
This file was last modified Friday 31st 2013f May 2013 08:37:15 GMT |
|
|
|
